ASTEC718.10

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,600 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt493.9554.5448.9448.9
Net Debt493.4554.0438.9438.9
Total Debt/Equity1.342.361.151.15
Net Debt/Equity1.342.361.121.12
Total Debt/EBITDA-83.53-8.38-99.19-99.19
Net Debt/EBITDA-83.45-8.37-96.9775.75
Interest Coverage (EBIT/Interest)-1.67-3.00-1.43-1.43
Total Debt/Total Capital %57.2070.2353.4553.45
As Filed — company-reported covenants
Debt/Equity (as filed)1.000.98
Debt Service Coverage (as filed)0.01
Interest Service Coverage (as filed)1.000.03
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.